Idera Pharmaceuticals (IDRA) Posts Q2 Loss of 23c, Beats Views
Tweet
Share
E-mailGet Alerts IDRA Hot Sheet
Join SI Premium – FREE
Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) reported Q2 EPS of ($0.23), $0.02 better than the analyst estimate of ($0.25). Revenue for the quarter came in at $33 thousand versus the consensus estimate of $4.4 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ondas Holdings Inc. (ONDS) Misses Q2 EPS by 9c
- Cellebrite DI Ltd. (CLBT) Tops Q2 EPS by 4c ; Offers Guidance
- Bending Spoons S.p.A. (BSP) Tops Q2 EPS by 19c; offers guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
